RPL7 Antibody
Référence MBS8582385-0,1mL-FITC
Conditionnement : 0.1mL(FITC)
Marque : MyBiosource
RPL7 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8582385MBS8582385 is an antibody targeting RPL7. Also known as RPL7 Antibody. Reactive in Human, Mouse, Rat, Bovine, Chicken, Monkey, Pig. Host: Rabbit. Rabbit polyclonal antibody to RPL7 More details
Product Overview
Online Datasheet in PDFProduct Name
RPL7, Polyclonal Antibody
Full Product Name
RPL7 Antibody
Product Gene Name
anti-RPL7 antibody
Product Synonym Names
60S ribosomal protein L7
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Bovine, Chicken, Monkey, Pig
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of RPL7 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
29,226 Da
Chromosome Location
Chromosome: 8; NC_000008.10 (74202874..74205869, complement). Location: 8q21.11
OMIM
604166
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human RPL7. The exact sequence is proprietary.
Product Categories/Family for anti-RPL7 antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-RPL7 antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-RPL7 antibody
WB: 1:500-1:1000
IHC: 1:50-1:200
IHC: 1:50-1:200
Other Notes
Small volumes of anti-RPL7 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for RPL7. It may not necessarily be applicable to this product.
NCBI Official Full Name
60S ribosomal protein L7
NCBI Official Synonym Full Names
ribosomal protein L7
NCBI Official Symbol
RPL7
NCBI Official Synonym Symbols
L7; humL7-1
UniProt Protein Name
60S ribosomal protein L7
Protein Family
60S ribosomal protein
UniProt Gene Name
RPL7
UniProt Entry Name
RL7_HUMAN
NCBI Protein Information
60S ribosomal protein L7
NCBI Summary for RPL7
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L30P family of ribosomal proteins. It contains an N-terminal basic region-leucine zipper (BZIP)-like domain and the RNP consensus submotif RNP2. In vitro the BZIP-like domain mediates homodimerization and stable binding to DNA and RNA, with a preference for 28S rRNA and mRNA. The protein can inhibit cell-free translation of mRNAs, suggesting that it plays a regulatory role in the translation apparatus. It is located in the cytoplasm. The protein has been shown to be an autoantigen in patients with systemic autoimmune diseases, such as systemic lupus erythematosus. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for RPL7
RPL7: a ribosomal protein of the L30P family. Located in the cytoplasm. Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This protein is a component of the 60S subunit. Contains an N-terminal basic region-leucine zipper (BZIP)-like domain and the RNP consensus submotif RNP2. In vitro the BZIP-like domain mediates homodimerization and stable binding to DNA and RNA, with a preference for 28S rRNA and mRNA. Can inhibit cell-free translation of mRNAs, suggesting that it plays a regulatory role in the translation apparatus.
Protein type: RNA processing; Nuclear receptor co-regulator; Ribosomal
Chromosomal Location of Human Ortholog: 8q21.11
Cellular Component: focal adhesion; membrane; cytoplasm; nucleolus; cytosol; ribonucleoprotein complex; nucleus
Molecular Function: mRNA binding; protein binding; protein homodimerization activity; structural constituent of ribosome; DNA binding; RNA binding
Biological Process: SRP-dependent cotranslational protein targeting to membrane; translation; viral reproduction; translational termination; ribosomal large subunit biogenesis and assembly; viral infectious cycle; cellular protein metabolic process; translational elongation; mRNA catabolic process, nonsense-mediated decay; translational initiation; viral transcription; gene expression; rRNA processing
Show more Protein type: RNA processing; Nuclear receptor co-regulator; Ribosomal
Chromosomal Location of Human Ortholog: 8q21.11
Cellular Component: focal adhesion; membrane; cytoplasm; nucleolus; cytosol; ribonucleoprotein complex; nucleus
Molecular Function: mRNA binding; protein binding; protein homodimerization activity; structural constituent of ribosome; DNA binding; RNA binding
Biological Process: SRP-dependent cotranslational protein targeting to membrane; translation; viral reproduction; translational termination; ribosomal large subunit biogenesis and assembly; viral infectious cycle; cellular protein metabolic process; translational elongation; mRNA catabolic process, nonsense-mediated decay; translational initiation; viral transcription; gene expression; rRNA processing
Research Articles on RPL7
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-RPL7 antibody
| Reference Product | PubMed Publications |
|---|---|
| ZNF7 antibody | >1 publications with RPL7 and ZNF7 |
Pathways associated with anti-RPL7 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Cap-dependent Translation Initiation Pathway antibodies | Cap-dependent Translation Initiation Pathway Diagram |
| Cytoplasmic Ribosomal Proteins Pathway antibodies | Cytoplasmic Ribosomal Proteins Pathway Diagram |
| Disease Pathway antibodies | Disease Pathway Diagram |
| Eukaryotic Translation Elongation Pathway antibodies | Eukaryotic Translation Elongation Pathway Diagram |
| Eukaryotic Translation Initiation Pathway antibodies | Eukaryotic Translation Initiation Pathway Diagram |
| Eukaryotic Translation Termination Pathway antibodies | Eukaryotic Translation Termination Pathway Diagram |
| Formation Of A Pool Of Free 40S Subunits Pathway antibodies | Formation Of A Pool Of Free 40S Subunits Pathway Diagram |
| GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway antibodies | GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway Diagram |
| Gene Expression Pathway antibodies | Gene Expression Pathway Diagram |
| Influenza Infection Pathway antibodies | Influenza Infection Pathway Diagram |
Diseases associated with anti-RPL7 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >5 publications with RPL7 and Neoplasms |
| Anemia Antibodies | >3 publications with RPL7 and Anemia |
| Kidney Diseases Antibodies | >2 publications with RPL7 and Kidney Diseases |
| Breast Neoplasms Antibodies | >1 publications with RPL7 and Breast Neoplasms |
| Fibrosis Antibodies | >1 publications with RPL7 and Fibrosis |
| Proteinuria Antibodies | >1 publications with RPL7 and Proteinuria |
| Heart Diseases Antibodies | >1 publications with RPL7 and Heart Diseases |
| Cell Transformation, Neoplastic Antibodies | >1 publications with RPL7 and Cell Transformation, Neoplastic |
| Inflammation Antibodies | >1 publications with RPL7 and Inflammation |
Organs/Tissues associated with anti-RPL7 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >9 publications with RPL7 and Blood |
| Brain Antibodies | >6 publications with RPL7 and Brain |
| Connective Tissue Antibodies | >5 publications with RPL7 and Connective Tissue |
| Lung Antibodies | >3 publications with RPL7 and Lung |
| Liver Antibodies | >2 publications with RPL7 and Liver |
| Heart Antibodies | >2 publications with RPL7 and Heart |
| Kidney Antibodies | >2 publications with RPL7 and Kidney |
| Bone Antibodies | >1 publications with RPL7 and Bone |
| Muscle Antibodies | >1 publications with RPL7 and Muscle |
| Lymph Antibodies | >1 publications with RPL7 and Lymph |


